{"ok":true,"object":{"id":"atm_site_06c609249d3f2417b338","kind":"Website","name":"Being Patient","parent_id":null,"depth":null,"facts":{"url":"https://beingpatient.com/","host":"beingpatient.com","forms":14,"marin":false,"pages":4,"listings":1,"site_kind":"unknown","found_from":"https://www.nationalgeographic.com/health/article/alzheimers-drugs-blood-brain-barrier"},"source_id":"src_5ad3cc6df1d1e72a55ad","updated_at":"2026-10-14T09:03:23.955Z","type":"Feature","geometry":null,"links":{"self":"https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338","children":"https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/children","descendants":"https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/descendants","inside":"https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/inside","graph":"https://miscsubjects.com/atlas/graph?start=atm_site_06c609249d3f2417b338","page":"https://miscsubjects.com/graph/atlas:atm_site_06c609249d3f2417b338","json":"https://miscsubjects.com/graph/atlas:atm_site_06c609249d3f2417b338.json"},"ancestors":[],"children_by_kind":[],"edges_out":[{"rel":"links_to","id":"atm_site_ce995e622ce9027e3c0a","kind":"GovernmentWebsite","name":"National Center for Biotechnology Information","share":1},{"rel":"links_to","id":"atm_site_038efb649ce1c0d48a21","kind":"Website","name":"NEW POLL: D.C. Policy Influencers, Small Business Owners and American Voters Demand U.S. Companies Receive Fair Treatmen","share":1},{"rel":"links_to","id":"atm_site_055878d4c9c9aa326800","kind":"Website","name":"Instagram","share":2},{"rel":"links_to","id":"atm_site_47ae5ac8229e87684334","kind":"Website","name":"404 | LEQEMBI® (lecanemab-irmb)","share":1},{"rel":"links_to","id":"atm_site_b04bb21c46b2524c3f18","kind":"Website","name":"ns","share":2},{"rel":"links_to","id":"atm_site_b63cd5966bac444c92b2","kind":"Website","name":"Just a moment...","share":1},{"rel":"links_to","id":"atm_site_b994407a8106a51ab870","kind":"Website","name":"Donanemab Approval Likely to Pose New Quandaries for Clinicians | ALZFORUM","share":1},{"rel":"links_to","id":"atm_site_c99fa6738e0b7b99bab3","kind":"Website","name":"Just a moment...","share":1},{"rel":"publishes","id":"atm_form_089011ef471493e4af55","kind":"Form","name":"Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient","share":null},{"rel":"publishes","id":"atm_form_29341dd47af2ff8272d5","kind":"Form","name":"Latest News | Being Patient","share":null},{"rel":"publishes","id":"atm_form_bdc4c8fb5f51a8f32bf8","kind":"Form","name":"Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient","share":null},{"rel":"publishes","id":"atm_form_d33f19c629efc200b4b1","kind":"Form","name":"Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient","share":null},{"rel":"publishes","id":"atm_form_d8295a16b4e925effba5","kind":"Form","name":"Brain Health and Dementia | Being Patient","share":null}],"edges_in":[{"rel":"links_to","id":"atm_site_40126b6e630ae2e3993f","kind":"Website","name":"Education | National Geographic Society","share":1}],"edges_in_total":1,"external_ids":[],"source":{"id":"src_5ad3cc6df1d1e72a55ad","url":null,"license":"public web pages, robots.txt honoured","read_at":"2026-10-13T23:21:09.844Z","sha256":"208b3244e04e88f503da63917fd963b3f4f5a70528be355db4d5f625a8a28164"},"observations":[],"edges_out_total":13,"entities":{"atm_site_06c609249d3f2417b338":{"id":"atm_site_06c609249d3f2417b338","label":"Being Patient","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_06c609249d3f2417b338","json":"https://miscsubjects.com/graph/atlas:atm_site_06c609249d3f2417b338.json"},"atm_site_ce995e622ce9027e3c0a":{"id":"atm_site_ce995e622ce9027e3c0a","label":"National Center for Biotechnology Information","type":"GovernmentWebsite","page":"https://miscsubjects.com/graph/atlas:atm_site_ce995e622ce9027e3c0a","json":"https://miscsubjects.com/graph/atlas:atm_site_ce995e622ce9027e3c0a.json"},"atm_site_038efb649ce1c0d48a21":{"id":"atm_site_038efb649ce1c0d48a21","label":"NEW POLL: D.C. Policy Influencers, Small Business Owners and American Voters Demand U.S. Companies Receive Fair Treatmen","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_038efb649ce1c0d48a21","json":"https://miscsubjects.com/graph/atlas:atm_site_038efb649ce1c0d48a21.json"},"atm_site_055878d4c9c9aa326800":{"id":"atm_site_055878d4c9c9aa326800","label":"Instagram","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_055878d4c9c9aa326800","json":"https://miscsubjects.com/graph/atlas:atm_site_055878d4c9c9aa326800.json"},"atm_site_47ae5ac8229e87684334":{"id":"atm_site_47ae5ac8229e87684334","label":"404 | LEQEMBI® (lecanemab-irmb)","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_47ae5ac8229e87684334","json":"https://miscsubjects.com/graph/atlas:atm_site_47ae5ac8229e87684334.json"},"atm_site_b04bb21c46b2524c3f18":{"id":"atm_site_b04bb21c46b2524c3f18","label":"ns","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_b04bb21c46b2524c3f18","json":"https://miscsubjects.com/graph/atlas:atm_site_b04bb21c46b2524c3f18.json"},"atm_site_b63cd5966bac444c92b2":{"id":"atm_site_b63cd5966bac444c92b2","label":"Just a moment...","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_b63cd5966bac444c92b2","json":"https://miscsubjects.com/graph/atlas:atm_site_b63cd5966bac444c92b2.json"},"atm_site_b994407a8106a51ab870":{"id":"atm_site_b994407a8106a51ab870","label":"Donanemab Approval Likely to Pose New Quandaries for Clinicians | ALZFORUM","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_b994407a8106a51ab870","json":"https://miscsubjects.com/graph/atlas:atm_site_b994407a8106a51ab870.json"},"atm_site_c99fa6738e0b7b99bab3":{"id":"atm_site_c99fa6738e0b7b99bab3","label":"Just a moment...","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_c99fa6738e0b7b99bab3","json":"https://miscsubjects.com/graph/atlas:atm_site_c99fa6738e0b7b99bab3.json"},"atm_form_089011ef471493e4af55":{"id":"atm_form_089011ef471493e4af55","label":"Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient","type":"Form","page":"https://miscsubjects.com/graph/atlas:atm_form_089011ef471493e4af55","json":"https://miscsubjects.com/graph/atlas:atm_form_089011ef471493e4af55.json"},"atm_form_29341dd47af2ff8272d5":{"id":"atm_form_29341dd47af2ff8272d5","label":"Latest News | Being Patient","type":"Form","page":"https://miscsubjects.com/graph/atlas:atm_form_29341dd47af2ff8272d5","json":"https://miscsubjects.com/graph/atlas:atm_form_29341dd47af2ff8272d5.json"},"atm_form_bdc4c8fb5f51a8f32bf8":{"id":"atm_form_bdc4c8fb5f51a8f32bf8","label":"Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient","type":"Form","page":"https://miscsubjects.com/graph/atlas:atm_form_bdc4c8fb5f51a8f32bf8","json":"https://miscsubjects.com/graph/atlas:atm_form_bdc4c8fb5f51a8f32bf8.json"},"atm_form_d33f19c629efc200b4b1":{"id":"atm_form_d33f19c629efc200b4b1","label":"Leqembi Vs. Kisunla: An Alzheimer's Drug Point-by-Point Comparison | Being Patient","type":"Form","page":"https://miscsubjects.com/graph/atlas:atm_form_d33f19c629efc200b4b1","json":"https://miscsubjects.com/graph/atlas:atm_form_d33f19c629efc200b4b1.json"},"atm_form_d8295a16b4e925effba5":{"id":"atm_form_d8295a16b4e925effba5","label":"Brain Health and Dementia | Being Patient","type":"Form","page":"https://miscsubjects.com/graph/atlas:atm_form_d8295a16b4e925effba5","json":"https://miscsubjects.com/graph/atlas:atm_form_d8295a16b4e925effba5.json"},"atm_site_40126b6e630ae2e3993f":{"id":"atm_site_40126b6e630ae2e3993f","label":"Education | National Geographic Society","type":"Website","page":"https://miscsubjects.com/graph/atlas:atm_site_40126b6e630ae2e3993f","json":"https://miscsubjects.com/graph/atlas:atm_site_40126b6e630ae2e3993f.json"}},"relationships":{"upward":{"predicate":"part_of","parent_ref":null,"ancestors":[],"order":"nearest parent first"},"downward":{"predicate":"part_of","total":0,"by_kind":[]},"sideways":{"outgoing":{"returned":13,"total":13,"items":[{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_ce995e622ce9027e3c0a","ref":"atm_site_ce995e622ce9027e3c0a"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_038efb649ce1c0d48a21","ref":"atm_site_038efb649ce1c0d48a21"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_055878d4c9c9aa326800","ref":"atm_site_055878d4c9c9aa326800"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_47ae5ac8229e87684334","ref":"atm_site_47ae5ac8229e87684334"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_b04bb21c46b2524c3f18","ref":"atm_site_b04bb21c46b2524c3f18"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_b63cd5966bac444c92b2","ref":"atm_site_b63cd5966bac444c92b2"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_b994407a8106a51ab870","ref":"atm_site_b994407a8106a51ab870"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"links_to","object":"atm_site_c99fa6738e0b7b99bab3","ref":"atm_site_c99fa6738e0b7b99bab3"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"publishes","object":"atm_form_089011ef471493e4af55","ref":"atm_form_089011ef471493e4af55"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"publishes","object":"atm_form_29341dd47af2ff8272d5","ref":"atm_form_29341dd47af2ff8272d5"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"publishes","object":"atm_form_bdc4c8fb5f51a8f32bf8","ref":"atm_form_bdc4c8fb5f51a8f32bf8"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"publishes","object":"atm_form_d33f19c629efc200b4b1","ref":"atm_form_d33f19c629efc200b4b1"},{"subject":"atm_site_06c609249d3f2417b338","predicate":"publishes","object":"atm_form_d8295a16b4e925effba5","ref":"atm_form_d8295a16b4e925effba5"}]},"incoming":{"returned":1,"total":1,"items":[{"subject":"atm_site_40126b6e630ae2e3993f","predicate":"links_to","object":"atm_site_06c609249d3f2417b338","ref":"atm_site_40126b6e630ae2e3993f"}]},"json":"https://miscsubjects.com/atlas/atoms/atm_site_06c609249d3f2417b338/edges?limit=100&offset=0"}},"reference_contract":{"entity_lookup":"entities[ref]","directions":"Parent/ancestors and children describe the stored parent hierarchy. Edges retain their own predicates and subject/object direction; they do not imply containment.","counts":"Counts refer to source objects, not necessarily distinct people or physical properties. A null total is unknown, not zero.","pagination":"Child pages use limit (maximum 500), offset and optional kind. Edge pages apply offset separately to incoming and outgoing lists. Follow each canonical JSON link to continue traversal.","fact_scope":"Facts belong to this object. Collection membership, professional presence, mailing city and an associated parcel do not establish residence or transfer jurisdiction.","source_hash":"source.sha256 describes the source provenance; it is not a hash of this JSON response."}}}